TAMSULOSIN HYDROCHLORIDE
Generic: TAMSULOSIN HYDROCHLORIDE
XLCare PharmaceuticalsManufacturer
ORALRoute
TAMSULOSIN HYDROCHLORIDEActive Substance
2022-05-04Original Approval
TAMSULOSIN HYDROCHLORIDE is FDA application ANDA214730, sponsored by ASCENT PHARMS INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2019-07-17
Tamsulosin Hydrochloride Capsules, USP 0.4 mg Rx only a) 100 count (NDC 33342-159-11), b) 500 count (NDC 33342-159-15)Failed Dissolution Specifications
Class II2019-02-22
Tamsulosin Hydrochloride Capsules, USP, 0.4 mg, 500-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., MuFailed Dissolution Specifications: High Out-of-Specification dissolution results were observed durin
Top Reported Reactions
1
FATIGUE
1,564 reports
2
DYSPNOEA
1,506 reports
3
DIZZINESS
1,315 reports
4
DIARRHOEA
1,287 reports
5
OFF LABEL USE
1,072 reports
6
DRUG INEFFECTIVE
1,026 reports
7
HEADACHE
1,007 reports
8
FALL
941 reports
9
ASTHENIA
933 reports
10
NAUSEA
906 reports